Philip A. Leighton

机构：Adamas Pharmaceuticals (United States), OmniActive Health Technologies (Canada), Joint BioEnergy Institute · ORCID：0000-0002-6575-129X

发表论文 119 篇 · 总被引 5452 次 · h-index 31

代表论文

• Germline transmission of genetically modified primordial germ cells (2006 · Nature · 被引 500)
• Production of human monoclonal antibody in eggs of chimeric chickens (2005 · Nature Biotechnology · 被引 232)
• Immunoglobulin knockout chickens via efficient homologous recombination in primordial germ cells (2013 · Proceedings of the National Academy of Sciences · 被引 165)
• High-grade transgenic somatic chimeras from chicken embryonic stem cells (2005 · Mechanisms of Development · 被引 117)
• Germline Gene Editing in Chickens by Efficient CRISPR-Mediated Homologous Recombination in Primordial Germ Cells (2016 · PLoS ONE · 被引 114)
• Interspecific Germline Transmission of Cultured Primordial Germ Cells (2012 · PLoS ONE · 被引 76)